Related Experiment Video
Updated: Jan 9, 2026

Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses
Published on: March 29, 2017
Neuroimmune interactions in inflammatory bowel disease: Role of intestinal macrophages and the cholinergic pathway
1Department of Gastroenterology, Shaanxi Hospital of Traditional Chinese Medicine, Xi'an 710003, Shaanxi Province, China.
Abstract:
The molecular mechanisms by which the autonomic nervous system regulates immune cell function have become a popular research topic. The discovery that vagus nerve stimulation (VNS) alleviates endotoxemia has laid an important foundation for further study of the neuroimmune system. This review focuses on the latest insights related to intestinal neurons and macrophages (Mφs) and outlines the mechanisms underlying cholinergic control of inflammation and key electrophysiological VNS approaches for the treatment of inflammatory bowel disease (IBD). Mφs are the most important antigen-presenting cells in the human body and exist in various forms. In the gut, Mφs can maintain the intestinal balance by engulfing and digesting microorganisms. However, macrophage overactivation results in the production of excessive inflammatory mediators, which can damage the intestinal mucosa and induce an inflammatory response, leading to IBD. The role of cholinergic anti-inflammatory mechanisms in immune-mediated IBD have attracted substantial attention. Mφs are a special type of phagocytes that play a crucial role in maintaining intestinal homeostasis and movement. In the intestinal tract, Mφ is classified into different subgroups based on its position in the parietal layer and is closely related to the microenvironment.
More Related Videos
06:57Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
Published on: September 18, 2016
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
Related Concept Videos
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Parasympathetic Signaling
The effects of...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...